Clinical TopicsContraceptivesContraceptivesFamily PlanningNewsNP VoicesNPWH NewsPregnancy and PostpartumWomen's Health
Dr. Komkwuan P. Paruchabutr, DNP, WHNP-BC, FNP-BC, CNM, FACNM

NPWH President-elect to Appear Before FDA at OTC Contraception Hearing

Author(s): By Dave Gilmartin
Share

NPWH’s President-elect will be offering oral arguments this week during an FDA hearing on making a contraception pill available over-the-counter (OTC).

Dr. Komkwuan P. Paruchabutr, DNP, WHNP-BC, FNP-BC, CNM, FACNM
Dr. Komkwuan P. Paruchabutr, DNP, WHNP-BC, FNP-BC, CNM, FACNM

Dr. Komkwuan P. Paruchabutr, DNP, WHNP-BC, FNP-BC, CNM, FACNM, NPWH President-Elect and Co-Chair, NPWH Advocacy and Government Relations Committee, will be supporting making the Opill birth control pill available OTC during the FDA Joint Meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive, and Urologic Drugs Advisory Committee.

It is the first time the FDA has considered the possibility of giving OTC status to a birth control pill.

“NPWH believes and fully supports access to OTC HC (hormone contraception) will help patients of all ages live healthier lives,” the association noted in promoting a virtual watch party being held Tuesday and Wednesday to follow oral arguments and hear live commentary. “The research is thorough and clear. Guided by clear evidence and thorough data, NPWH fully supports making Opill available OTC.”

More than three-quarters of women ages 18-49 also support making birth control available without a prescription if they are shown to be safe and effective, according to a Kaiser Family Foundation survey released last year. Among those who favored OTC status of the pills, 60% said they would likely use them.

NPWH, in written testimony submitted to the FDA, noted that the safety of hormone contraception is well established.

“HC is one of the most widely used and extensively studied medications on the market. Over sixty years of research and data show that oral contraception is safe and effective. Decades of documentation demonstrate a low prevalence of contraindications for people of all ages,” NPWH wrote in its statement.

 

Nurse Practitioners interested in attending the virtual watch party for the FDA hearing should register here today (May 8).  Free the Pill, of which NPWH is a member, is sponsoring the event from 9:30 to 5:30 ET Tuesday and 9:30 to 1:30 ET Wednesday.


The contents of this feature are not provided or reviewed by NPWH.

Get your free subscription to the Women's Healthcare Newsletter!

Women's Healthcare Newsletter Sidebar

Enter your email to receive our bi-weekly newsletter from the publishers of Women's Healthcare

  • This field is for validation purposes and should be left unchanged.
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Quiz

According to the CDC, approximately how many women will develop breast cancer in their life?

Let Us Know What You Think

Poll